Use of Biochemical Markers for Risk Stratification and Choice of Therapy in Acute Coronary Syndromes: Lessons from the FRISC II & GUSTO IV (+FRISC I & FAST) Trials
Bertil Lindahl
Figure 1. Typical disposition of patients presenting with suspected acute coronary syndrome.
